secwatch.observer — SEC 8-K summary
======================================

Issuer:     MeiraGTx Holdings plc (MGTX)
CIK:        0001735438
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001558370-22-017297
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MeiraGTx reports Q3 2022 net loss $37.3M; receives $25M investment from JJDC
----------------------------------------------------------------------------

- Net loss of $37.3M ($0.83 per share) vs $25.9M ($0.59) in Q3 2021.
- License revenue of $4.8M, down from $6.9M YoY on lower amortization from Janssen.
- Cash and equivalents $114.7M at Sept 30 plus $23.7M receivables from Janssen; funded into Q4 2024.
- Received $25M private placement from JJDC at $6.68/share (3.74M shares) for preclinical and manufacturing.
- Dosing Phase 1 AAV-GAD for Parkinson's; XLRP Phase 3 LUMEOS on track for BLA in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1735438/000155837022017297/0001558370-22-017297-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1735438/000155837022017297/mgtx-20221109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-017297

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer